Annual CFI
-$3.92 M
+$31.10 M+88.80%
December 31, 2023
Summary
- As of February 27, 2025, STRO annual cash flow from investing activities is -$3.92 million, with the most recent change of +$31.10 million (+88.80%) on December 31, 2023.
- During the last 3 years, STRO annual CFI has fallen by -$4.53 million (-749.67%).
- STRO annual CFI is now -112.04% below its all-time high of $32.60 million, reached on December 31, 2017.
Performance
STRO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$147.29 M
+$227.66 M+283.25%
September 30, 2024
Summary
- As of February 27, 2025, STRO quarterly cash flow from investing activities is $147.29 million, with the most recent change of +$227.66 million (+283.25%) on September 30, 2024.
- Over the past year, STRO quarterly CFI has increased by +$170.80 million (+726.42%).
- STRO quarterly CFI is now at all-time high.
Performance
STRO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$107.51 M
+$261.31 M+169.90%
September 30, 2024
Summary
- As of February 27, 2025, STRO TTM cash flow from investing activities is $107.51 million, with the most recent change of +$261.31 million (+169.90%) on September 30, 2024.
- Over the past year, STRO TTM CFI has increased by +$111.43 million (+2839.73%).
- STRO TTM CFI is now at all-time high.
Performance
STRO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
STRO Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +88.8% | +726.4% | +2839.7% |
| 3 y3 years | -749.7% | +726.4% | +2839.7% |
| 5 y5 years | +95.1% | +726.4% | +2839.7% |
STRO Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +96.0% | at high | +229.2% | at high | +169.9% |
| 5 y | 5-year | -749.7% | +96.0% | at high | +221.0% | at high | +166.1% |
| alltime | all time | -112.0% | +96.0% | at high | +221.0% | at high | +166.1% |
Sutro Biopharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $147.29 M(-283.3%) | $107.51 M(-169.9%) |
| Jun 2024 | - | -$80.38 M(-225.4%) | -$153.80 M(+2015.6%) |
| Mar 2024 | - | $64.11 M(-372.6%) | -$7.27 M(+85.3%) |
| Dec 2023 | -$3.92 M(-88.8%) | -$23.51 M(-79.4%) | -$3.92 M(-78.5%) |
| Sep 2023 | - | -$114.02 M(-272.3%) | -$18.29 M(-203.4%) |
| Jun 2023 | - | $66.16 M(-1.9%) | $17.69 M(-3298.7%) |
| Mar 2023 | - | $67.45 M(-278.1%) | -$553.00 K(-98.4%) |
| Dec 2022 | -$35.02 M(-64.0%) | -$37.88 M(-51.5%) | -$35.02 M(-248.1%) |
| Sep 2022 | - | -$78.04 M(-262.9%) | $23.64 M(-76.2%) |
| Jun 2022 | - | $47.91 M(+45.3%) | $99.44 M(+73.2%) |
| Mar 2022 | - | $32.98 M(+58.7%) | $57.40 M(-159.0%) |
| Dec 2021 | -$97.31 M | $20.78 M(-1026.9%) | -$97.31 M(-4.9%) |
| Sep 2021 | - | -$2.24 M(-138.2%) | -$102.29 M(+2.5%) |
| Jun 2021 | - | $5.88 M(-104.8%) | -$99.75 M(-38.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$121.73 M(-870.1%) | -$162.76 M(<-9900.0%) |
| Dec 2020 | $604.00 K(-101.2%) | $15.81 M(+5240.2%) | $604.00 K(-108.3%) |
| Sep 2020 | - | $296.00 K(-100.5%) | -$7.26 M(-422.0%) |
| Jun 2020 | - | -$57.14 M(-237.2%) | $2.25 M(-96.7%) |
| Mar 2020 | - | $41.64 M(+424.3%) | $68.58 M(-234.1%) |
| Dec 2019 | -$51.13 M(-36.2%) | $7.94 M(-19.1%) | -$51.13 M(-10.4%) |
| Sep 2019 | - | $9.81 M(+6.7%) | -$57.05 M(-61.6%) |
| Jun 2019 | - | $9.19 M(-111.8%) | -$148.68 M(-5.8%) |
| Mar 2019 | - | -$78.08 M(-3955.8%) | -$157.91 M(+96.9%) |
| Dec 2018 | -$80.19 M(-346.0%) | $2.02 M(-102.5%) | -$80.19 M(-2.5%) |
| Sep 2018 | - | -$81.81 M(>+9900.0%) | -$82.22 M(>+9900.0%) |
| Jun 2018 | - | -$36.00 K(-90.1%) | -$400.00 K(+9.9%) |
| Mar 2018 | - | -$364.00 K | -$364.00 K |
| Dec 2017 | $32.60 M(+239.9%) | - | - |
| Dec 2016 | $9.59 M | - | - |
FAQ
- What is Sutro Biopharma annual cash flow from investing activities?
- What is the all time high annual CFI for Sutro Biopharma?
- What is Sutro Biopharma annual CFI year-on-year change?
- What is Sutro Biopharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Sutro Biopharma?
- What is Sutro Biopharma quarterly CFI year-on-year change?
- What is Sutro Biopharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for Sutro Biopharma?
- What is Sutro Biopharma TTM CFI year-on-year change?
What is Sutro Biopharma annual cash flow from investing activities?
The current annual CFI of STRO is -$3.92 M
What is the all time high annual CFI for Sutro Biopharma?
Sutro Biopharma all-time high annual cash flow from investing activities is $32.60 M
What is Sutro Biopharma annual CFI year-on-year change?
Over the past year, STRO annual cash flow from investing activities has changed by +$31.10 M (+88.80%)
What is Sutro Biopharma quarterly cash flow from investing activities?
The current quarterly CFI of STRO is $147.29 M
What is the all time high quarterly CFI for Sutro Biopharma?
Sutro Biopharma all-time high quarterly cash flow from investing activities is $147.29 M
What is Sutro Biopharma quarterly CFI year-on-year change?
Over the past year, STRO quarterly cash flow from investing activities has changed by +$170.80 M (+726.42%)
What is Sutro Biopharma TTM cash flow from investing activities?
The current TTM CFI of STRO is $107.51 M
What is the all time high TTM CFI for Sutro Biopharma?
Sutro Biopharma all-time high TTM cash flow from investing activities is $107.51 M
What is Sutro Biopharma TTM CFI year-on-year change?
Over the past year, STRO TTM cash flow from investing activities has changed by +$111.43 M (+2839.73%)